|
General Information
|
|
|
Product
|
MYLK3 Peptide
|
|
Description
|
Antigenic Blocking Peptide Myosin light chain kinase 3 Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 10-60 on human Myosin light chain kinase 3 protein.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q32MK0
|
|
Overview
|
Kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes and increases cardiomyocyte contractility.
|
|
Molecular Function
|
ATP binding
calmodulin-dependent protein kinase activity
myosin light chain kinase activity
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Restricted to heart.
|
|
Structure
|
Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.
|
|
Alternative Nomenclature
|
caMLCK antibody
cardiac MLCK antibody
Cardiac MyBP C associated Ca/CaM kinase antibody
MLC kinase antibody
MLCK antibody
MLCK2 antibody
Mylk3 antibody
Myosin light chain kinase 3 antibody
Putative myosin light chain kinase 3 antibody
|
|
|
|
MYLK3 Antibody
MYLK3 Antibody BIOTIN
MYLK3 Antibody FITC
MYLK3 Positive Control
